Maria Eugenia Marques da Costa

9PUBLICATIONS
160CO-AUTHORS
Molecular targetsPredictive and prognostic markersNanomedicineSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jul 03, 2026
Spatial transcriptomic atlas of aggressive osteosarcomas reveals shared immune landscape and targetable surface markers.

|Sep 13, 2024
TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma.

Grégoire Gessain, Ahmed-Amine Anzali, Marvin Lerousseau

|Sep 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors.

Maria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec

|Jan 05, 2023
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models.

Elizabeth R Tucker, Irene Jiménez, Lindi Chen

|Jan 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis.

Antonin Marchais, Maria Eugenia Marques da Costa, Bastien Job

Pageof 2

Frequent Collaborators

7 joint publications

Birgit Geoerger

3 joint publications

Jean-Yves Scoazec

3 joint publications

Didier Surdez

3 joint publications

Olivier Delattre